ALNY - Alnylam Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALNY is currently covered by 26 analysts with an average price target of $272.99. This is a potential upside of $42.06 (18.21%) from yesterday's end of day stock price of $230.93.

Alnylam Pharmaceuticals's activity chart (see below) currently has 407 price targets and 452 ratings on display. The stock rating distribution of ALNY is 74.66% BUY and 25.34% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.68% with an average time for these price targets to be met of 227.15 days.

Highest price target for ALNY is $500, Lowest price target is $234, average price target is $310.58.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 11-Apr-2025.

Currently out of the existing stock ratings of ALNY, 109 are a BUY (74.66%), 37 are a HOLD (25.34%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$268

$30.23 (12.71%)

$284

4 days ago
(11-Apr-2025)

9/10 (90%)

$30.23 (12.71%)

41

Buy

$320

$82.23 (34.58%)

$320

6 days ago
(09-Apr-2025)

12/20 (60%)

$76.73 (31.54%)

215

Buy

$500

$262.23 (110.29%)

$500

13 days ago
(02-Apr-2025)

1/25 (4%)

$233.17 (87.39%)

664

Buy

$342

$104.23 (43.84%)

$338

15 days ago
(31-Mar-2025)

0/5 (0%)

$71.98 (26.66%)

Buy

$345

$107.23 (45.10%)

$295

15 days ago
(31-Mar-2025)

17/18 (94.44%)

$74.98 (27.77%)

247

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?

On average it took 227.15 days on average for the stock forecasts to be realized with a an average price target met ratio 82.68

Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?

WHITNEY IJEM

Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?

Whitney Ijem works at CANACCORD and has 19 price targets and 11 ratings on ALNY

Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?

Patrick Trucchio with highest potential upside - $262.23

Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?

Christopher Marai with lowest potential downside - -$163.77

Alnylam Pharmaceuticals in the News

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US administration announced numerous executive...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?